Another day and another medical app. This one from JNCCN– Journal of the National Comprehensive Cancer Network – the only journal that publishes the most commonly used guidelines for cancer therapy. Follow more content on your iOS mobile device.
Read JNCCN on the go!
Coming in the October issue of JNCCN:
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
NEW! NCCN Guidelines® Insights
Waldenström's Macroglobulinemia/ Lymphoplasmacytic Lymphoma, Version 1.201
Despite common and occasionally serious side effects, androgen deprivation therapy is widely used in the management of prostate cancer, including situations that lack evidence of benefit.
The most important next step in using the techniques now available for personalized treatment of acute myeloid leukemia is developing effective and safe strategies for eradicating the residual leukemic cells that are likely chemoresistant.
This article provides a systematic and comprehensive review of the literature to address the clinical and pathologic features recognized in pancreas cancer pertaining to thrombosis and to discuss ongoing investigations of prophylactic anticoagulation.
NCCN Molecular Testing White Paper: Effectiveness, Efficiency, and Reimbursement (Volume 9, Supplement 6)
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology(Volume 9, Supplement 5)
NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives (Volume 9, Supplement 4)
Category: Pathology News